Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cytosorbents Corporation CTSO

Full chart Compare
Set alert

Price alert · CTSO

All alert types
4.54 USD +0.78 (+20.74%)

At closeNov 3, 2026, 4:00 PM EST

4.70 +0.16 +3.52%

After hours · Nov 3, 4:00 PM ET

4.11 Day range 4.67
2.84 52-week range 17.00
YTD
-64.48%
1 year
-70.93%

Financial health

Altman Z-Score

-12.29 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -4.9×
FY 2016: -11.6×FY 2017: -21.0×FY 2018: -14.4×FY 2019: -6.4×FY 2020: -39.9×FY 2021: -7.4×FY 2022: -2.1×FY 2023: -1.7×FY 2024: -2.4×FY 2025: -4.9×
FY 2016 5y median -2.4× FY 2025
P/S 1.1×
FY 2016: 16.9×FY 2017: 13.4×FY 2018: 12.3×FY 2019: 5.5×FY 2020: 7.8×FY 2021: 4.5×FY 2022: 1.9×FY 2023: 1.6×FY 2024: 1.4×FY 2025: 1.1×
FY 2016 5y median 1.6× FY 2025
P/B 6.7×
FY 2016: -292×FY 2017: 17.5×FY 2018: 14.7×FY 2019: 36.3×FY 2020: 3.9×FY 2021: 2.9×FY 2022: 1.9×FY 2023: 2.1×FY 2024: 4.5×FY 2025: 6.7×
FY 2016 5y median 2.9× FY 2025
P/FCF -3.2×
FY 2016: -18.9×FY 2017: -22.1×FY 2018: -20.1×FY 2019: -6.8×FY 2020: -42.4×FY 2021: -9.9×FY 2022: -1.9×FY 2023: -2.2×FY 2024: -3.4×FY 2025: -3.2×
FY 2016 5y median -3.2× FY 2025
EV/EBITDA -14.4×
FY 2016: -11.7×FY 2017: -21.1×FY 2018: -14.8×FY 2019: -6.9×FY 2020: -24.6×FY 2021: -5.9×FY 2022: -2.1×FY 2023: -1.9×FY 2024: -3.8×FY 2025: -14.4×
FY 2016 5y median -3.8× FY 2025
EV/Sales 1.7×
FY 2016: 16.9×FY 2017: 12.9×FY 2018: 11.6×FY 2019: 5.6×FY 2020: 6.1×FY 2021: 3.6×FY 2022: 1.8×FY 2023: 1.7×FY 2024: 2.1×FY 2025: 1.7×
FY 2016 5y median 1.8× FY 2025
FCF Yield -31.5%
FY 2016: -5.3%FY 2017: -4.5%FY 2018: -5.0%FY 2019: -14.7%FY 2020: -2.4%FY 2021: -10.1%FY 2022: -51.4%FY 2023: -45.6%FY 2024: -29.7%FY 2025: -31.5%
FY 2016 5y median -31.5% FY 2025

Profitability

Gross Margin 71.5%
FY 2016: 51.8%FY 2017: 58.8%FY 2018: 63.0%FY 2019: 67.7%FY 2020: 72.0%FY 2021: 72.5%FY 2022: 59.8%FY 2023: 70.6%FY 2024: 69.9%FY 2025: 71.5%
FY 2016 5y median 70.6% FY 2025
Operating Margin -38.4%
FY 2016: -140.0%FY 2017: -73.6%FY 2018: -77.0%FY 2019: -83.3%FY 2020: -26.3%FY 2021: -56.7%FY 2022: -90.9%FY 2023: -102.8%FY 2024: -46.2%FY 2025: -38.4%
FY 2016 5y median -56.7% FY 2025
Net Margin -22.1%
FY 2016: -145.5%FY 2017: -63.2%FY 2018: -85.0%FY 2019: -84.6%FY 2020: -19.9%FY 2021: -61.2%FY 2022: -94.6%FY 2023: -94.1%FY 2024: -58.2%FY 2025: -22.1%
FY 2016 5y median -61.2% FY 2025
ROE -138.9%
FY 2016: 2518.3%FY 2017: -82.4%FY 2018: -101.6%FY 2019: -563.7%FY 2020: -9.9%FY 2021: -39.2%FY 2022: -92.8%FY 2023: -125.7%FY 2024: -186.5%FY 2025: -138.9%
FY 2016 5y median -125.7% FY 2025
ROIC -38.8%
FY 2016: -252.2%FY 2017: -45.0%FY 2018: -55.2%FY 2019: -89.9%FY 2020: -11.3%FY 2021: -28.9%FY 2022: -56.9%FY 2023: -74.7%FY 2024: -40.0%FY 2025: -38.8%
FY 2016 5y median -40.0% FY 2025
ROA -18.6%
FY 2016: -123.2%FY 2017: -35.1%FY 2018: -52.6%FY 2019: -70.4%FY 2020: -8.7%FY 2021: -27.4%FY 2022: -51.9%FY 2023: -54.9%FY 2024: -43.7%FY 2025: -18.6%
FY 2016 5y median -43.7% FY 2025

Growth (YoY)

Revenue 4.1%
FY 2016: 102.3%FY 2017: 63.1%FY 2018: 51.3%FY 2019: 12.4%FY 2020: 73.3%FY 2021: 1.7%FY 2022: -13.5%FY 2023: -10.4%FY 2024: 14.5%FY 2025: 4.1%
FY 2016 FY 2025
Operating Income 13.5%
FY 2016: -23.5%FY 2017: 14.4%FY 2018: -58.3%FY 2019: -21.7%FY 2020: 45.3%FY 2021: -119.3%FY 2022: -38.6%FY 2023: -1.4%FY 2024: 48.5%FY 2025: 13.5%
FY 2016 FY 2025
EPS (diluted) 65.8%
FY 2016: -42.4%FY 2017: 34.0%FY 2018: -80.6%FY 2019: -7.1%FY 2020: 66.7%FY 2021: -185.0%FY 2022: -31.6%FY 2023: 13.3%FY 2024: 41.5%FY 2025: 65.8%
FY 2016 FY 2025
Free Cash Flow 14.8%
FY 2016: 24.1%FY 2017: -11.1%FY 2018: -51.9%FY 2019: -47.9%FY 2020: 60.1%FY 2021: -150.9%FY 2022: -89.7%FY 2023: 34.9%FY 2024: 34.9%FY 2025: 14.8%
FY 2016 FY 2025

Financial Health

Current Ratio 2.1×
FY 2016: 1.3×FY 2017: 2.6×FY 2018: 4.3×FY 2019: 2.1×FY 2020: 8.1×FY 2021: 4.7×FY 2022: 3.5×FY 2023: 1.8×FY 2024: 2.2×FY 2025: 2.1×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 1.6×
FY 2016: 1.1×FY 2017: 2.5×FY 2018: 4.2×FY 2019: 1.9×FY 2020: 7.9×FY 2021: 4.3×FY 2022: 3.1×FY 2023: 1.5×FY 2024: 1.9×FY 2025: 1.6×
FY 2016 5y median 1.9× FY 2025
Debt / Equity 4.9×
FY 2016: -10.4×FY 2017: 1.0×FY 2018: 0.6×FY 2019: 4.8×FY 2020: 0.0×FY 2021: 0.2×FY 2022: 0.5×FY 2023: 0.8×FY 2024: 2.4×FY 2025: 4.9×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA -5.2×
FY 2016: 0.0×FY 2017: 0.9×FY 2018: 0.8×FY 2019: -0.2×FY 2020: 7.2×FY 2021: 1.6×FY 2022: 0.1×FY 2023: -0.2×FY 2024: -1.2×FY 2025: -5.2×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -5.5×
FY 2016: -49.6×FY 2017: -13.1×FY 2018: -10.7×FY 2019: -18.4×FY 2020: -8.6×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -202×FY 2024: -11.8×FY 2025: -5.5×
FY 2016 5y median -5.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.2%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: -4.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31